Some of the 17 million Americans afflicted with major depressive disorder may soon receive a surprising prescription from their clinician: Have fun on a VR device.
The rapidly evolving SARS-CoV-2 virus threatens the progress made in curbing the COVID-19 pandemic. A promising novel drug candidate, designed at the atomic level, could help doctors halt the rise of lethal new drug resistant variants.
New Stanford research adds to evidence that the seasonality of respiratory illnesses, like COVID-19 or the flu, can be linked to indoor humidity levels.
A molecular “snapshot” of a protein can be critical to understanding its function. Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer treatments.
Accidental exposure to allergy-triggering foods can have life-threatening consequences for children with food allergies. A new treatment reduces the risk.
Anxiety and depression among Latino groups in the United States have risen during times of heightened enforcement and policy tug-of-war, new research shows.
